Abstract:
The invention relates to a group of hydronopol derivatives which are agonists on human ORL1 (nociceptin) receptors. The invention also relates to the preparation of these compounds, to pharmaceutical compositions containing a pharmacologically active amount of at least one of these novel hydronopol derivatives as an active ingredient, as well as to the use of these pharmaceutical compositions for the treatment of disorders in which ORL1 receptors are involved. The invention relates to compounds of the general formula (1) wherein the symbols have the meanings as given in the description.
Abstract:
Novel 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]--piperazine compounds which are antagonistic to tachykinin receptors, of the general formula I, (see formula I) wherein R6, R7, A and Z have the meanings given in the description, and medicaments containing these compounds are described. Furthermore, a process for the preparation of the novel compounds and intermediate products of this process are described.
Abstract:
Deriváty N-triazomethyl-piperazinu obecného vzorce I, kde substituenty mají specifický význam, které úcinne antagonisticky pusobí na neurokininové receptory. Jsou popsány zpusoby výroby derivátu N-triazolylmethylpiperazinu a meziprodukty techto výrob a také léciva s obsahem slouceniny obecného vzorce I.
Abstract:
4-substituted 1-amidomethylcarbonyl-piperidine compounds having motilin-agonistic properties and their acid addition salts, pharmaceutical compositions containing these compounds, processes and intermediate products for the preparation of these compounds, and methods of treatment utilizing these compounds.
Abstract:
N-triazolylmethyl-piperazine derivatives which exhibit neurokinin receptor antagonistic activity corresponding to the formula (I), wherein R1, R2 and R3 have the meanings given in the specification, pharmaceutical compositions containing these compounds. A process for preparing these compounds and intermediate products of this processes.
Abstract:
The use of 5-phenyl-3H-1,2-dithiole-3-thione S-oxides which are optionally substituted in the phenyl ring as active compounds in liver-protective medicines and 5-phenyl-3H-1,2-dithiole-3-thione S-oxides substituted in the phenyl ring are described.